NF-kB is upregulated in a variety of tissues with aging, and the inhibition of NF-kB has been shown to delay the onset of aging-related symptoms and pathologies such as diabetes, atherosclerosis, and tumor (Kanigur Sultuybek et al., 2019). The gene discussed is NFKB1; the disease is diabetes mellitus.